Lee's Pharmaceutical Holdings Ltd
HKEX:950

Watchlist Manager
Lee's Pharmaceutical Holdings Ltd Logo
Lee's Pharmaceutical Holdings Ltd
HKEX:950
Watchlist
Price: 1.56 HKD 0.65%
Market Cap: HK$918.6m

Net Margin

6.8%
Current
Improving
by 2.1%
vs 3-y average of 4.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.8%
=
Net Income
HK$97.8m
/
Revenue
HK$1.4B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.8%
=
Net Income
HK$97.8m
/
Revenue
HK$1.4B

Peer Comparison

Country Company Market Cap Net
Margin
HK
Lee's Pharmaceutical Holdings Ltd
HKEX:950
918.6m HKD
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...

Market Distribution

Higher than 74% of companies in Hong Kong
Percentile
74th
Based on 3 006 companies
74th percentile
6.8%
Low
-239 513 300% — -12.9%
Typical Range
-12.9% — 5.3%
High
5.3% — 203 056%
Distribution Statistics
Hong Kong
Min -239 513 300%
30th Percentile -12.9%
Median 0.5%
70th Percentile 5.3%
Max 203 056%

Lee's Pharmaceutical Holdings Ltd
Glance View

Market Cap
918.6m HKD
Industry
Pharmaceuticals

Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. The firm operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The firm mainly operates businesses in China and Hong Kong.

Intrinsic Value
2 HKD
Undervaluation 22%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
6.8%
=
Net Income
HK$97.8m
/
Revenue
HK$1.4B
What is Lee's Pharmaceutical Holdings Ltd's current Net Margin?

The current Net Margin for Lee's Pharmaceutical Holdings Ltd is 6.8%, which is above its 3-year median of 4.7%.

How has Net Margin changed over time?

Over the last 3 years, Lee's Pharmaceutical Holdings Ltd’s Net Margin has increased from -10.5% to 6.8%. During this period, it reached a low of -10.5% on May 30, 2022 and a high of 6.8% on Jul 30, 2025.

Back to Top